{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:45:05Z","timestamp":1789994705770,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1002\/jps.20051","type":"journal-article","created":{"date-parts":[[2004,3,25]],"date-time":"2004-03-25T22:01:28Z","timestamp":1080252088000},"page":"1431-1439","source":"Crossref","is-referenced-by-count":74,"title":["Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate"],"prefix":"10.1016","volume":"93","author":[{"given":"Araz A.","family":"Raoof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeibun","family":"Ramtoola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain K.","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chingleou","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Weinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg E.","family":"Hardee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20051_bb0010","series-title":"Biotechnology and safety assessment","first-page":"23","article-title":"Antigens therapeutics","author":"Crooke","year":"1998"},{"key":"10.1002\/jps.20051_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/13543784.8.3.237","article-title":"Antisense oligonucleotide therapeutics","volume":"8","author":"Bennett","year":"1999","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1002\/jps.20051_bb0020","series-title":"Gene therapy","article-title":"Antisense oligonucleotide\u2010based therapeutics","author":"Bennett","year":"2000"},{"key":"10.1002\/jps.20051_bb0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/scientificamerican1198-46b","article-title":"Shutting down a gene. Antigens drug wins approval","volume":"279","author":"Stixt","year":"1998","journal-title":"Sci Am"},{"key":"10.1002\/jps.20051_bb0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jps.2600820902","article-title":"Gastrointestinal parameters that influence oral medications","volume":"82","author":"Dressman","year":"1993","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20051_bb0035","first-page":"898","article-title":"Absolute bioavailability of 2\u2032\u2010O\u2010(2\u2010methoxyethyl)\u2010modified antigens oligonucleotides following intraduodenal instillation in rats","volume":"296","author":"Geary","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20051_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20051_bb0045","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.2042-7158.1987.tb03124.x","article-title":"Enhancement of jejunal and colonic absorption of fosfomycin by promoters in the rat","volume":"39","author":"Ishizawa","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.20051_bb0050","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1023\/A:1012112219578","article-title":"Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate","volume":"14","author":"Lindmark","year":"1997","journal-title":"Pharm Res"},{"issue":"Suppl","key":"10.1002\/jps.20051_bb0055","first-page":"16","article-title":"The role of tumor necrosis factor in health and disease","volume":"57","author":"Beutler","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1002\/jps.20051_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/phrs.1998.0463","article-title":"The role of TNF in cardiovascular disease","volume":"40","author":"Ferrari","year":"1999","journal-title":"Pharmacol Res"},{"issue":"Suppl","key":"10.1002\/jps.20051_bb0065","first-page":"7","article-title":"The immunology of sepsis and meningitis\u2013cytokine biology","volume":"73","author":"Jacobs","year":"1990","journal-title":"Scand J Infect Dis"},{"issue":"Suppl","key":"10.1002\/jps.20051_bb0070","first-page":"S415","article-title":"Tumor necrosis factor: An updated review of its biology","volume":"21","author":"Tracey","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1002\/jps.20051_bb0075","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V88.5.1788.1788","article-title":"Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation","volume":"88","author":"Zhao","year":"1996","journal-title":"Blood"},{"key":"10.1002\/jps.20051_bb0080","first-page":"379","article-title":"Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues","volume":"77","author":"Butler","year":"1997","journal-title":"Lab Invest"},{"key":"10.1002\/jps.20051_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-4781(99)00140-2","article-title":"A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides","volume":"1489","author":"Levin","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.20051_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/abio.1999.4290","article-title":"A nonradioisotope biomedical assay for intact oligonucleotide and its chain\u2010shortened metabolites used for determination of exposure and elimination half\u2010life of antisense drugs in tissue","volume":"274","author":"Geary","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1002\/jps.20051_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/abio.1996.0088","article-title":"Quantitation of phosphorothioate oligonucelotides in human plasma","volume":"235","author":"Leeds","year":"1996","journal-title":"Anal Biochem"},{"key":"10.1002\/jps.20051_bb0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0928-0987(02)00162-8","article-title":"Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs","volume":"17","author":"Raoof","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.20051_bb0105","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.3168\/jds.S0022-0302(91)78509-3","article-title":"The composition of milk fat","volume":"74","author":"Jenson","year":"1991","journal-title":"J Dairy Sci"},{"key":"10.1002\/jps.20051_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1016353705970","article-title":"Comparison of canine and human gastrointestinal physiology","volume":"3","author":"Dressman","year":"1986","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20051_bb0115","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1023\/A:1014822219133","article-title":"Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha\u2010ras encapsulated in stealth liposomes","volume":"16","author":"Yu","year":"1999","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20051_bb0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/1520-6017(200102)90:2<182::AID-JPS9>3.0.CO;2-F","article-title":"Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha\u2010ras mRNA in mouse and monkey","volume":"90","author":"Yu","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20051_bb0125","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/jpet.102.036749","article-title":"Phase I trial of ISIS 104838, a 2\u2032\u2010methoxyethyl modified antigens oligonucleotide targeting tumour necrosis factor\u2010alpha","volume":"303","author":"Sewell","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20051_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1018909210879","article-title":"Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route","volume":"10","author":"Anderberg","year":"1993","journal-title":"Pharm Res"},{"key":"10.1002\/jps.20051_bb0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1248\/bpb.21.615","article-title":"Effectiveness and toxicity screening of various absorption enhancers using Caco\u20102 cell monolayers","volume":"21","author":"Quan","year":"1998","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.20051_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5173(99)00213-6","article-title":"In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology","volume":"191","author":"Chao","year":"1999","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916315350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916315350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T20:09:16Z","timestamp":1585685356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916315350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0022354916315350"],"URL":"https:\/\/doi.org\/10.1002\/jps.20051","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}